APO Research
Talk to an analyst

APO RESEARCH · REPORT

Dexamethasone Implant

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Dexamethasone Implant Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

27 December 2025181 pages

Choose your research edition.

Industry ResearchDexamethasone Implant Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Dexamethasone Implant Industry Growth and Trends Forecast to 203294 pages · $3,450 USDMarket StructureGlobal Dexamethasone Implant Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032181 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Dexamethasone Implant Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Dexamethasone Implant Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Dexamethasone Implant market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Dexamethasone Implant is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Dexamethasone Implant is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Dexamethasone Implant is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Dexamethasone Implant is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Dexamethasone Implant include AbbVie, Curia, EyePoint, Ocular Therapeutix, AffaMed Therapeutics and Ocumension Therapeutics, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Dexamethasone Implant market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Dexamethasone Implant and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Dexamethasone Implant sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Dexamethasone Implant market size, projected growth trends, production technologies, key applications, and end-use industries.

Dexamethasone Implant Segment by Company

AbbVie

Curia

EyePoint

Ocular Therapeutix

AffaMed Therapeutics

Ocumension Therapeutics

Dexamethasone Implant Segment by Type

0.7mg

0.35mg

Dexamethasone Implant Segment by Application

Clinic

Hospital

Others

Dexamethasone Implant Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Dexamethasone Implant market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Dexamethasone Implant and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Dexamethasone Implant.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Dexamethasone Implant market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Dexamethasone Implant manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Dexamethasone Implant in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Dexamethasone Implant in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Dexamethasone Implant Industry Trends Table 2. Dexamethasone Implant Industry Drivers Table 3. Dexamethasone Implant Industry Opportunities and Challenges Table 4. Dexamethasone Implant Industry Restraints Table 5. Global Dexamethasone Implant Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Dexamethasone Implant Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Dexamethasone Implant Sales by Manufacturers (Units) & (2021-2026) Table 8. Global Dexamethasone Implant Sales Market Share by Manufacturers Table 9. Global Dexamethasone Implant Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Dexamethasone Implant Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Dexamethasone Implant Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Dexamethasone Implant Manufacturers, Product Type & Application Table 13. Global Dexamethasone Implant Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Dexamethasone Implant by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of 0.7mg Table 17. Major Manufacturers of 0.35mg Table 18. Global Dexamethasone Implant Sales by Type 2021 VS 2025 VS 2032 (Units) Table 19. Global Dexamethasone Implant Sales by Type (2021-2026) & (Units) Table 20. Global Dexamethasone Implant Sales by Type (2027-2032) & (Units) Table 21. Global Dexamethasone Implant Sales Market Share by Type (2021-2026) Table 22. Global Dexamethasone Implant Sales Market Share by Type (2027-2032) Table 23. Global Dexamethasone Implant Revenue by Type 2021 VS 2025 VS 2032 (Units) Table 24. Global Dexamethasone Implant Revenue by Type (2021-2026) & (Units) Table 25. Global Dexamethasone Implant Revenue by Type (2027-2032) & (Units) Table 26. Global Dexamethasone Implant Revenue Market Share by Type (2021-2026) Table 27. Global Dexamethasone Implant Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Clinic Table 29. Major Manufacturers of Hospital Table 30. Major Manufacturers of Others Table 31. Global Dexamethasone Implant Sales by Application 2021 VS 2025 VS 2032 (Units) Table 32. Global Dexamethasone Implant Sales by Application (2021-2026) & (Units) Table 33. Global Dexamethasone Implant Sales by Application (2027-2032) & (Units) Table 34. Global Dexamethasone Implant Sales Market Share by Application (2021-2026) Table 35. Global Dexamethasone Implant Sales Market Share by Application (2027-2032) Table 36. Global Dexamethasone Implant Revenue by Application 2021 VS 2025 VS 2032 (Units) Table 37. Global Dexamethasone Implant Revenue by Application (2021-2026) & (Units) Table 38. Global Dexamethasone Implant Revenue by Application (2027-2032) & (Units) Table 39. Global Dexamethasone Implant Revenue Market Share by Application (2021-2026) Table 40. Global Dexamethasone Implant Revenue Market Share by Application (2027-2032) Table 41. Global Dexamethasone Implant Sales by Region: 2021 VS 2025 VS 2032 (Units) Table 42. Global Dexamethasone Implant Sales by Region (2021-2026) & (Units) Table 43. Global Dexamethasone Implant Sales Market Share by Region (2021-2026) Table 44. Global Dexamethasone Implant Sales Forecasted by Region (2027-2032) & (Units) Table 45. Global Dexamethasone Implant Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Dexamethasone Implant Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Units) Table 47. North America Dexamethasone Implant Sales by Country (2021-2026) & (Units) Table 48. North America Dexamethasone Implant Sales by Country (2027-2032) & (Units) Table 49. Europe Dexamethasone Implant Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Units) Table 50. Europe Dexamethasone Implant Sales by Country (2021-2026) & (Units) Table 51. Europe Dexamethasone Implant Sales by Country (2027-2032) & (Units) Table 52. Asia Pacific Dexamethasone Implant Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Units) Table 53. Asia Pacific Dexamethasone Implant Sales by Country (2021-2026) & (Units) Table 54. Asia Pacific Dexamethasone Implant Sales by Country (2027-2032) & (Units) Table 55. South America, Middle East and Africa Dexamethasone Implant Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Units) Table 56. South America, Middle East and Africa Dexamethasone Implant Sales by Country (2021-2026) & (Units) Table 57. South America, Middle East and Africa Dexamethasone Implant Sales by Country (2027-2032) & (Units) Table 58. Global Dexamethasone Implant Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Dexamethasone Implant Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Dexamethasone Implant Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Dexamethasone Implant Revenue Market Share by Region (2021-2026) Table 62. Global Dexamethasone Implant Revenue Market Share by Region (2027-2032) Table 63. AbbVie Company Information Table 64. AbbVie Business Overview Table 65. AbbVie Dexamethasone Implant Sales (Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. AbbVie Dexamethasone Implant Product Portfolio Table 67. AbbVie Recent Development Table 68. Curia Company Information Table 69. Curia Business Overview Table 70. Curia Dexamethasone Implant Sales (Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Curia Dexamethasone Implant Product Portfolio Table 72. Curia Recent Development Table 73. EyePoint Company Information Table 74. EyePoint Business Overview Table 75. EyePoint Dexamethasone Implant Sales (Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. EyePoint Dexamethasone Implant Product Portfolio Table 77. EyePoint Recent Development Table 78. Ocular Therapeutix Company Information Table 79. Ocular Therapeutix Business Overview Table 80. Ocular Therapeutix Dexamethasone Implant Sales (Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Ocular Therapeutix Dexamethasone Implant Product Portfolio Table 82. Ocular Therapeutix Recent Development Table 83. AffaMed Therapeutics Company Information Table 84. AffaMed Therapeutics Business Overview Table 85. AffaMed Therapeutics Dexamethasone Implant Sales (Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. AffaMed Therapeutics Dexamethasone Implant Product Portfolio Table 87. AffaMed Therapeutics Recent Development Table 88. Ocumension Therapeutics Company Information Table 89. Ocumension Therapeutics Business Overview Table 90. Ocumension Therapeutics Dexamethasone Implant Sales (Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Ocumension Therapeutics Dexamethasone Implant Product Portfolio Table 92. Ocumension Therapeutics Recent Development Table 93. Key Raw Materials Table 94. Raw Materials Key Suppliers Table 95. Dexamethasone Implant Distributors List Table 96. Dexamethasone Implant Customers List Table 97. Research Programs/Design for This Report Table 98. Authors List of This Report Table 99. Secondary Sources Table 100. Primary Sources List of Figures Figure 1. Dexamethasone Implant Product Image Figure 2. Global Dexamethasone Implant Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Dexamethasone Implant Market Size (2021-2032) & (US$ Million) Figure 4. Global Dexamethasone Implant Sales (2021-2032) & (Units) Figure 5. Global Dexamethasone Implant Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Dexamethasone Implant Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. 0.7mg Image Figure 9. 0.35mg Image Figure 10. Global Dexamethasone Implant Sales by Type (2021 VS 2025 VS 2032) & (Units) Figure 11. Global Dexamethasone Implant Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Dexamethasone Implant Sales Market Share by Type (2021-2032) Figure 13. Global Dexamethasone Implant Revenue by Type (2021 VS 2025 VS 2032) & (Units) Figure 14. Global Dexamethasone Implant Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Dexamethasone Implant Revenue Market Share by Type (2021-2032) Figure 16. Clinic Image Figure 17. Hospital Image Figure 18. Others Image Figure 19. Global Dexamethasone Implant Sales by Application (2021 VS 2025 VS 2032) & (Units) Figure 20. Global Dexamethasone Implant Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Dexamethasone Implant Sales Market Share by Application (2021-2032) Figure 22. Global Dexamethasone Implant Revenue by Application (2021 VS 2025 VS 2032) & (Units) Figure 23. Global Dexamethasone Implant Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Dexamethasone Implant Revenue Market Share by Application (2021-2032) Figure 25. North America Dexamethasone Implant Sales and Growth Rate (2021-2032) & (Units) Figure 26. North America Dexamethasone Implant Sales Market Share by Country (2021-2032) Figure 27. U.S. Dexamethasone Implant Sales and Growth Rate (2021-2032) & (Units) Figure 28. Canada Dexamethasone Implant Sales and Growth Rate (2021-2032) & (Units) Figure 29. Mexico Dexamethasone Implant Sales and Growth Rate (2021-2032) & (Units) Figure 30. Europe Dexamethasone Implant Sales and Growth Rate (2021-2032) & (Units) Figure 31. Europe Dexamethasone Implant Sales Market Share by Country (2021-2032) Figure 32. Germany Dexamethasone Implant Sales and Growth Rate (2021-2032) & (Units) Figure 33. France Dexamethasone Implant Sales and Growth Rate (2021-2032) & (Units) Figure 34. U.K. Dexamethasone Implant Sales and Growth Rate (2021-2032) & (Units) Figure 35. Italy Dexamethasone Implant Sales and Growth Rate (2021-2032) & (Units) Figure 36. Netherlands Dexamethasone Implant Sales and Growth Rate (2021-2032) & (Units) Figure 37. Asia Pacific Dexamethasone Implant Sales and Growth Rate (2021-2032) & (Units) Figure 38. Asia Pacific Dexamethasone Implant Sales Market Share by Country (2021-2032) Figure 39. China Dexamethasone Implant Sales and Growth Rate (2021-2032) & (Units) Figure 40. Japan Dexamethasone Implant Sales and Growth Rate (2021-2032) & (Units) Figure 41. South Korea Dexamethasone Implant Sales and Growth Rate (2021-2032) & (Units) Figure 42. Southeast Asia Dexamethasone Implant Sales and Growth Rate (2021-2032) & (Units) Figure 43. India Dexamethasone Implant Sales and Growth Rate (2021-2032) & (Units) Figure 44. Australia Dexamethasone Implant Sales and Growth Rate (2021-2032) & (Units) Figure 45. South America, Middle East and Africa Dexamethasone Implant Sales and Growth Rate (2021-2032) & (Units) Figure 46. South America, Middle East and Africa Dexamethasone Implant Sales Market Share by Country (2021-2032) Figure 47. Brazil Dexamethasone Implant Sales and Growth Rate (2021-2032) & (Units) Figure 48. South Africa Dexamethasone Implant Sales and Growth Rate (2021-2032) & (Units) Figure 49. Saudi Arabia Dexamethasone Implant Sales and Growth Rate (2021-2032) & (Units) Figure 50. Turkey Dexamethasone Implant Sales and Growth Rate (2021-2032) & (Units) Figure 51. Argentina Dexamethasone Implant Sales and Growth Rate (2021-2032) & (Units) Figure 52. UAE Dexamethasone Implant Sales and Growth Rate (2021-2032) & (Units) Figure 53. Egypt Dexamethasone Implant Sales and Growth Rate (2021-2032) & (Units) Figure 54. Chile Dexamethasone Implant Sales and Growth Rate (2021-2032) & (Units) Figure 55. Global Dexamethasone Implant Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Dexamethasone Implant Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Dexamethasone Implant Revenue (2021-2032) & (US$ Million) Figure 58. North America Dexamethasone Implant Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Dexamethasone Implant Revenue (2021-2032) & (US$ Million) Figure 60. Europe Dexamethasone Implant Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Dexamethasone Implant Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Dexamethasone Implant Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Dexamethasone Implant Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Dexamethasone Implant Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Dexamethasone Implant Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Dexamethasone Implant Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • 0.7mg
  • 0.35mg
Applications
  • Clinic
  • Hospital
  • Others
Companies covered
  • AbbVie
  • Curia
  • EyePoint
  • Ocular Therapeutix
  • AffaMed Therapeutics
  • Ocumension Therapeutics

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Dexamethasone Implant Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Dexamethasone Implant Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Dexamethasone Implant Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Dexamethasone Implant Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Dexamethasone Implant Market Dynamics
  1. 2.1 Dexamethasone Implant Industry Trends
  2. 2.2 Dexamethasone Implant Industry Drivers
  3. 2.3 Dexamethasone Implant Industry Opportunities and Challenges
  4. 2.4 Dexamethasone Implant Industry Restraints
3 Dexamethasone Implant Market by Manufacturers
  1. 3.1 Global Dexamethasone Implant Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Dexamethasone Implant Sales by Manufacturers (2021-2026)
  3. 3.3 Global Dexamethasone Implant Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Dexamethasone Implant Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Dexamethasone Implant Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Dexamethasone Implant Manufacturers, Product Type & Application
  7. 3.7 Global Dexamethasone Implant Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Dexamethasone Implant Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Dexamethasone Implant Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Dexamethasone Implant Tier 1, Tier 2, and Tier 3
4 Dexamethasone Implant Market by Type
  1. 4.1 Dexamethasone Implant Type Introduction
  2. 4.1.1 0.7mg
  3. 4.1.2 0.35mg
  4. 4.2 Global Dexamethasone Implant Sales by Type
  5. 4.2.1 Global Dexamethasone Implant Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Dexamethasone Implant Sales by Type (2021-2032)
  7. 4.2.3 Global Dexamethasone Implant Sales Market Share by Type (2021-2032)
  8. 4.3 Global Dexamethasone Implant Revenue by Type
  9. 4.3.1 Global Dexamethasone Implant Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Dexamethasone Implant Revenue by Type (2021-2032)
  11. 4.3.3 Global Dexamethasone Implant Revenue Market Share by Type (2021-2032)
5 Dexamethasone Implant Market by Application
  1. 5.1 Dexamethasone Implant Application Introduction
  2. 5.1.1 Clinic
  3. 5.1.2 Hospital
  4. 5.1.3 Others
  5. 5.2 Global Dexamethasone Implant Sales by Application
  6. 5.2.1 Global Dexamethasone Implant Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Dexamethasone Implant Sales by Application (2021-2032)
  8. 5.2.3 Global Dexamethasone Implant Sales Market Share by Application (2021-2032)
  9. 5.3 Global Dexamethasone Implant Revenue by Application
  10. 5.3.1 Global Dexamethasone Implant Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Dexamethasone Implant Revenue by Application (2021-2032)
  12. 5.3.3 Global Dexamethasone Implant Revenue Market Share by Application (2021-2032)
6 Global Dexamethasone Implant Sales by Region
  1. 6.1 Global Dexamethasone Implant Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Dexamethasone Implant Sales by Region (2021-2032)
  3. 6.2.1 Global Dexamethasone Implant Sales by Region (2021-2026)
  4. 6.2.2 Global Dexamethasone Implant Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Dexamethasone Implant Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Dexamethasone Implant Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Dexamethasone Implant Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Dexamethasone Implant Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Dexamethasone Implant Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Dexamethasone Implant Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Dexamethasone Implant Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Dexamethasone Implant Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Dexamethasone Implant Revenue by Region
  1. 7.1 Global Dexamethasone Implant Revenue by Region
  2. 7.1.1 Global Dexamethasone Implant Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Dexamethasone Implant Revenue by Region (2021-2026)
  4. 7.1.3 Global Dexamethasone Implant Revenue by Region (2027-2032)
  5. 7.1.4 Global Dexamethasone Implant Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Dexamethasone Implant Revenue (2021-2032)
  8. 7.2.2 North America Dexamethasone Implant Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Dexamethasone Implant Revenue (2021-2032)
  11. 7.3.2 Europe Dexamethasone Implant Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Dexamethasone Implant Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Dexamethasone Implant Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Dexamethasone Implant Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Dexamethasone Implant Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 AbbVie
  2. 8.1.1 AbbVie Company Information
  3. 8.1.2 AbbVie Business Overview
  4. 8.1.3 AbbVie Dexamethasone Implant Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 AbbVie Dexamethasone Implant Product Portfolio
  6. 8.1.5 AbbVie Recent Developments
  7. 8.2 Curia
  8. 8.2.1 Curia Company Information
  9. 8.2.2 Curia Business Overview
  10. 8.2.3 Curia Dexamethasone Implant Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Curia Dexamethasone Implant Product Portfolio
  12. 8.2.5 Curia Recent Developments
  13. 8.3 EyePoint
  14. 8.3.1 EyePoint Company Information
  15. 8.3.2 EyePoint Business Overview
  16. 8.3.3 EyePoint Dexamethasone Implant Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 EyePoint Dexamethasone Implant Product Portfolio
  18. 8.3.5 EyePoint Recent Developments
  19. 8.4 Ocular Therapeutix
  20. 8.4.1 Ocular Therapeutix Company Information
  21. 8.4.2 Ocular Therapeutix Business Overview
  22. 8.4.3 Ocular Therapeutix Dexamethasone Implant Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Ocular Therapeutix Dexamethasone Implant Product Portfolio
  24. 8.4.5 Ocular Therapeutix Recent Developments
  25. 8.5 AffaMed Therapeutics
  26. 8.5.1 AffaMed Therapeutics Company Information
  27. 8.5.2 AffaMed Therapeutics Business Overview
  28. 8.5.3 AffaMed Therapeutics Dexamethasone Implant Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 AffaMed Therapeutics Dexamethasone Implant Product Portfolio
  30. 8.5.5 AffaMed Therapeutics Recent Developments
  31. 8.6 Ocumension Therapeutics
  32. 8.6.1 Ocumension Therapeutics Company Information
  33. 8.6.2 Ocumension Therapeutics Business Overview
  34. 8.6.3 Ocumension Therapeutics Dexamethasone Implant Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Ocumension Therapeutics Dexamethasone Implant Product Portfolio
  36. 8.6.5 Ocumension Therapeutics Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Dexamethasone Implant Value Chain Analysis
  2. 9.1.1 Dexamethasone Implant Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Dexamethasone Implant Production Mode & Process
  6. 9.2 Dexamethasone Implant Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Dexamethasone Implant Distributors
  9. 9.2.3 Dexamethasone Implant Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst